Sygnis Pharma completes rights offering

Sygnis Pharma AG (Xetra:LIO1), Heidelberg, Germany Business: Genomics, Supply/Service Date completed: 2014-12-12 Type: Rights offering Raised: EUR5 million ($6.2 million) Shares: 2.5 million Price: €2...